SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin, $CAW, is trending with community members frequently repeating the phrase "crow with knife is the only option". The coin is described as multichain, deflationary, and community-driven, with supporters emphasizing its organic nature and active community.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as community members rally around the project's real-world applications and brand initiatives, including skateboards, energy drinks and more, with new products and partnerships being actively discussed. The community emphasizes its strong, active, and supportive nature, highlighting the various ways they are building the KENDU brand in real life. Bullish community members are focused on growing the brand and reaching new milestones.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto, $SLAP, is trending as the community rallies around it, using the term 'slap' to express enthusiasm and action against market downturns. Community members highlight the project's consistency, daily grind, and support from figures like MMA fighter Karolina Arm. Many express bullish sentiment and encourage others to 'slap' the competition and the bears.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending due to positive Phase 1 data for its CTX310 therapy, showing significant cholesterol reduction with a promising safety profile, sparking excitement about its potential. The community is discussing the implications of these results, especially the potential for a blockbuster drug and the validation of CRISPR's in vivo LNP delivery platform. Despite a recent price target reduction from Wedbush, the positive data and insider buying activity fuel optimism about the stock's future.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium (CCD) is trending due to its recent partnership with bitcoin.com for age-verified stablecoin payments, sparking community excitement and discussions around its potential. Some view CCD as an undervalued privacy and identity-focused project with strong long-term potential, drawing comparisons to ZEC. The project's focus on compliant, enterprise-ready blockchain solutions and growing institutional interest are also key talking points.

Monero

Monero is trending as the community emphasizes its role as a leading privacy coin, with some anticipating a significant breakout despite past delistings from major exchanges. Discussions highlight Monero's potential use cases amidst growing concerns over financial surveillance and the rise of CBDCs. Community members are also actively discussing mining Monero, viewing it as a means to secure the network and accumulate value.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is trending down sharply following news of a clinical hold on its MAGNITUDE trial due to liver toxicity concerns. The community is debating the severity of the issue, potential long-term impacts, and whether the sell-off is an overreaction, while also noting Cathie Wood's recent purchase of a million shares. Discussions include potential merger scenarios and speculation about insider information, alongside lowered price targets from analysts.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as community members rally behind its grassroots foundation and fair distribution, highlighting its potential as a leading meme coin on the Bitcoin network. Discussion focuses on the growing $DOG treasury and the increasing recognition from major players in the crypto space. Some community members also express excitement about potential exchange listings and increased exposure to retail investors.

Peanut the Squirrel Markets

$PNUT is trending amid community excitement and volatility, with traders actively discussing potential price movements and quick gains. Some users are comparing it to other meme coins like $DOGE and $SHIB, while others are focused on technical analysis and trading strategies to capitalize on short-term pumps. The coin seems to be benefiting from a broader meme coin rally, with community members expressing bullish sentiment and speculating on future price targets.

Veritone, Inc. engages in the provision of artificial intelligence (AI) computing solutions to media and entertainment, government, and legal and compliance industries. It operates through the following segments: Advertising, aiWARE SaaS Solutions, and aiWARE Content Licensing and Media Services. The Advertising segment places advertisements for clients, primarily with radio broadcasters, podcasters and digital media producers. The aiWARE SaaS Solutions segment offers solutions through a combination of its direct sales force and indirect channel partners, such as value-added resellers (VARs), distributors, system integrators, managed services providers, and referral partners. The aiWARE Content Licensing and Media Services segment sells and markets activities relating to its digital content licensing services business through its direct sales force. The company was founded by Chad Edward Steelberg and Ryan S. Steelberg on June 13, 2014 and is headquartered in Irvine, CA.

Veritone Inc

VERI is trending due to positive analyst coverage and discussions around its growth potential in the AI data refinement sector, particularly with its VDR product. Community members are actively discussing new partnerships with hyperscalers, revenue projections, and the company's strengthened balance sheet following debt reduction. Some are frustrated by recent price action, attributing it to market manipulation and dilution, while others remain bullish, anticipating significant upside and a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA (vutrisiran), an RNAi...

Here's How Much $1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today

What Does the Market Think About Alnylam Pharmaceuticals Inc?

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following upcoming investor conferences: UBS...

ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales

Alnylam's Q3 earnings and revenues surge past forecasts, powered by booming Amvuttra sales and a key milestone payment from Roche.

Compared to Estimates, Alnylam (ALNY) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates

Alnylam (ALNY) delivered earnings and revenue surprises of +73.65% and +22.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2025 and reviewed...

Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect

ZTS is poised for another earnings beat as rising demand for companion animal products like Simparica Trio and Apoquel drives expected Q3 revenue growth.

Amgen's Q3 Earnings in the Cards: Here's What to Expect 

Amgen's Q3 results are on deck, with growth from newer drugs offset by biosimilar competition and pricing pressures.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$442.70
Prev Close	$440.49
Open	$437.81
Dividend Yield	0.00%
50-Day Moving Average	$458.76
Beta	0.95
Avg. Volume	1.15M
PE Ratio	1,841.51

52-Week High	$495.55
52-Week Low	$205.87
Market Capitalization	$58.49B
EPS (Annual)	-$2.18
Price to Book	249.45
Revenue Per Employee	$1.01M
Enterprise Value/EBITDA	N/A

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc